Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This study is being conducted this study to determine whether injections of Xeomin®, a type
of botulinum toxin into the glands that produce saliva (one pair just below and in front of
the ear and the other just under the jaw line) are safe and effective to treat excessive
saliva, or drooling in patients with Parkinson's Disease (PD)/parkinsonism.